As Of	Filer	Filing¹	For·On·As	Docs:Size	Issuer		Filing Agent

 2/16/21  Lisata Therapeutics, Inc.         8-K:1,9     2/12/21    7:650K                                                            
 2/16/21  Lisata Therapeutics, Inc.         424B5                  1:435K                                                            
 2/16/21  Lisata Therapeutics, Inc.         424B5                  1:444K                                                            
 2/16/21  Armistice Capital, LLC            SC 13G/A               1:84K  Lisata Therapeutics, Inc.         Seward & Kissel LLP      

____________
¹	Filing/Form Types:  /A
	8-K	Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
	424B5	Prospectus – Primary Offering or Shelf Securities – New Facts or Events.
	SC 13G	Statement of Acquisition of Beneficial Ownership by a “Passive” Investor — Schedule 13G.
	/A	Amendment to, or Amended version of, a previous Filing of this Type.